Please provide your email address to receive an email when new articles are posted on . A multidisciplinary comprehensive obesity care model increased GLP-1 persistence at 1 year. Patients in the ...

MEDVi, a telehealth platform serving more than 100,000 patients, today announced an expanded physician-led program ...

“The GLP-1 landscape is expected to broaden significantly,” said Dr. Christopher McGowan, a gastroenterologist who runs a weight loss clinic in Cary, North Carolina. “For the first time, medical ...

Forbes contributors publish independent expert analyses and insights. Diane Omdahl is a Medicare expert who keeps her readers in the know. On December 23, the Centers for Medicare and Medicaid ...

Eli Lilly working Humana to distribute obesity medications through employer-focused programs via CenterWell Pharmacy.

Changes are coming in 2026 for GLP-1 drugs. Long defined by high prices, shortages and weekly injections, drugs including Wegovy and Zepbound are expected to be easier to access and afford. And new ...

Six of the clinical trials involved semaglutide — the ingredient used in Novo Nordisk's brands Ozempic and Wegovy — and ...